Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic
Janet M. Sasso, Rumiana Tenchov, Dasheng Wang, et al.
Biochemistry (2022) Vol. 62, Iss. 3, pp. 601-623
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Proximity-Based Modalities for Biology and Medicine
Xingui Liu, Alessio Ciulli
ACS Central Science (2023) Vol. 9, Iss. 7, pp. 1269-1284
Open Access | Times Cited: 73
Targeted protein degradation: from mechanisms to clinic
Jonathan M. Tsai, Radosław P. Nowak, Benjamin L. Ebert, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 9, pp. 740-757
Closed Access | Times Cited: 59
Affinity and cooperativity modulate ternary complex formation to drive targeted protein degradation
Ryan P. Wurz, Huan Rui, Ken Dellamaggiore, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 42
The emerging role of PI3K inhibitors for solid tumour treatment and beyond
Carmen Belli, Matteo Repetto, Santosh Anand, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 12, pp. 2150-2162
Open Access | Times Cited: 40
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton’s Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies
Daniel Robbins, Mark Noviski, Ying Siow Tan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2321-2336
Open Access | Times Cited: 26
Molecular glues for protein-protein interactions: Progressing toward a new dream
Markella Konstantinidou, Michelle R. Arkin
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1064-1088
Open Access | Times Cited: 17
Navigating the ERK1/2 MAPK Cascade
Ana Martín-Vega, Melanie H. Cobb
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1555-1555
Open Access | Times Cited: 31
Protein–protein interfaces in molecular glue-induced ternary complexes: classification, characterization, and prediction
Huan Rui, Kate S. Ashton, Jaeki Min, et al.
RSC Chemical Biology (2023) Vol. 4, Iss. 3, pp. 192-215
Open Access | Times Cited: 29
The rise of degrader drugs
Mingxing Teng, Nathanael S. Gray
Cell chemical biology (2023) Vol. 30, Iss. 8, pp. 864-878
Open Access | Times Cited: 25
Structure–Activity Relationship Study and Design Strategies of Hydantoin, Thiazolidinedione, and Rhodanine-Based Kinase Inhibitors: A Two-Decade Review
Muhammad Naufal, Elvira Hermawati, Yana Maolana Syah, et al.
ACS Omega (2024) Vol. 9, Iss. 4, pp. 4186-4209
Open Access | Times Cited: 6
Molecular glue degraders: exciting opportunities for novel drug discovery
Thomas Lemaître, Marie Cornu, Florian Schwalen, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 433-449
Closed Access | Times Cited: 6
Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
Matthew M. Weiss, Xiaozhang Zheng, Nan Ji, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 10548-10566
Closed Access | Times Cited: 6
Exploration of the Tunability of BRD4 Degradation by DCAF16 Trans-labelling Covalent Glues
Muhammad Murtaza Hassan, Yen-Der Li, W Michelle, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116904-116904
Open Access | Times Cited: 6
Routes to molecular glue degrader discovery
Yanfen Liu, Jieyun Bai, Dong Li, et al.
Trends in Biochemical Sciences (2025)
Closed Access
Discovery of a Potent and Selective GSPT1 Molecular Glue Degrader for the Treatment of Castration-Resistant Prostate Cancer
Hui Shen, Hongrui Xu, W. Q. Jin, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Discovery of novel benzosultam CRBN ligands
Hoyeong Park, Santosh Shivanand Raikar, Yonghyo Kim, et al.
Bulletin of the Korean Chemical Society (2025)
Closed Access
Research advancements in molecular glues derived from natural product scaffolds: Chemistry, targets, and molecular mechanisms
Lina Yin, Tingting Niu, Ling Li, et al.
Chinese Herbal Medicines (2025)
Open Access
Clozapine as an E3 Ligand for PROTAC Technology
Reina Takano, Nobumichi Ohoka, Takashi Kurohara, et al.
ACS Medicinal Chemistry Letters (2025)
Closed Access
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access
Myogenesis gone awry: the role of developmental pathways in rhabdomyosarcoma
Annika Gustafson, Adam D. Durbin, Kristin Artinger, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Leveraging Structural and Computational Biology for Molecular Glue Discovery
CongBao Kang, Weijun Xu
Journal of Medicinal Chemistry (2025)
Closed Access
Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders
Yanqing Zhang, Wenjing Liu, Chao Tong, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Development of Potent and Selective CK1α Molecular Glue Degraders
Qixiang Geng, Zixuan Jiang, Woong Sub Byun, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Design, Synthesis, and Antitumor Activity Study of Novel Potent Gspt1 Degraders
Li Zhang, Ling Wang, Meijing Deng, et al.
(2025)
Closed Access
Proteomic approaches advancing targeted protein degradation
Gajanan Sathe, Gopal P. Sapkota
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 11, pp. 786-801
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top